Symposium

[S18] Ophthalmic research update: toward the developments of new therapies

Sat. Mar 26, 2022 4:00 PM - 6:00 PM [Room O] Conference Room 234 (Bldg. 2: 3F)

Organizer: Shinsuke Nakamura (Gifu Pharm. Univ.), Kenji Sakamoto (Pharm-Sci.,Teikyo Univ.)

The healthcare environment in Japan is changing dramatically as we face a super-aged society. Morbidity of lots of ocular diseases are known to increase with aging. Vision accounts for a major portion of the information received by sensory organs in our daily lives, and visual function plays an extremely important role in maintaining and improving quality of life (QOL) and extending healthy life expectancy in the current information society. Against this background, there is a growing need to establish new preventive and therapeutic methods as well as early diagnostic techniques for various ocular diseases. In this symposium, up-and-coming researchers who are focusing their research on the eye will present their latest research, including research to reveal the pathogenesis of ocular diseases, applied research to develop new therapy for ocular diseases and research on drug delivery systems (DDS) aimed at improving the efficiency of drug delivery into the retina. We would like to provide useful knowledge for research not only in eye disease but also in other fields. In addition, we would like to give opportunities to experience mystery of the science of the eye, one of the smallest organs in the entire body.

+Add all to schedule

オーガナイザー挨拶：中村信介（岐阜薬大） (4:00 PM - 4:05 PM)

4:05 PM - 4:25 PM

[S18-1] Retinal vasodilation mediated by neurons and glial cells in rats

○Asami Mori^1,2, Takashi Uezono¹, Akane Morita², Tsutomu Nakahara², Kenji Sakamoto^1,2 (1. Fac. Pharma-Sci., Teikyo Univ., 2. Kitasato Univ. Sch. Pharm. Sci.)

4:25 PM - 4:45 PM

[S18-2] Glial dysfunction-caused age-associated optic nerve neuropathy

○Youichi Shinozaki^1,2, Alex Leung³, Kazuhiko Namekata⁴, Kenji Kashiwagi⁵, Nobuhiko Ohno^6,7, Eiji Shigetomi^1,2, Takahiro Segawa⁸, Takayuki Harada⁴, Shin-ichi Ohnuma³, Shuichi Koizumi^1,2 (1. Dept. Neuropharmacol., Interdiscip. Grad. Sch. Med. Univ. Yamanashi, 2. GLIA Center, Univ. Yamanashi, 3. Inst. Ophthalmol., UCL, 4. Vis. Res. Project, Tokyo Metr. Inst. Med. Sci., 5. Dept. Ophthalmol, Interdiscip. Grad. Sch. Med. Univ. Yamanashi, 6. Div. Ultrastruct. Res., Natl. Inst. Physiol. Sci., 7. Dept. Anat., Jichi Med. Univ., 8. Cent. Life Sci. Res., Univ. Yamanashi)

4:45 PM - 5:05 PM

[S18-3] Role of subcellular organelles in the stress response to the environmental risk factors associated with Retinal degenerative diseases

○Wataru Otsu¹ (1. Gifu Pharm. Univ.)

5:05 PM - 5:25 PM

[S18-4] Development of ocular nanoparticle DDS formulations for the therapy of posterior segment eye diseases

○Kohei Tahara¹, Takaaki Ito¹, Hirofumi Takeuchi¹ (1. Gifu Pharm. Univ.)

5:25 PM - 5:45 PM

[S18-5] Development of a selective EP2 receptor agonist, omidenepag isopropyl ophthalmic solution

○Masahiro Fuwa¹ (1. Santen Pharmaceutical Co., Ltd.)

総合討論、総括：坂本謙司（帝京大薬） (5:45 PM - 6:00 PM)

Session information